Biosimilar Use, Cost Trends In Medicare Part B Will Be Examined By HHS Inspector General

 
• By Cathy Kelly
  
magnified money
OIG Will Investigate Extent Of Savings From Biosimilars • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics